And several previous studies have explored CXCR4 expression in neuroendocrine tumors, but these studies generally took GEP-NENs as a whole rather than focusing on GEP-NENs G3, and the number of specimens included in these studies was also generally small (25–27). Here, CXCR4 is linked to neuroendocrine neoplasm.